Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$104,806
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 55 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-04-24 Dispersyn Gerrit Chief Development Officer Grant or award · Stock option (right to buy) +95,000 95,000
2017-03-17 CAUWENBERGH GEERT President & CEO Purchase +9,320 $0.77 $7K 101,903
2017-03-17 CAUWENBERGH GEERT President & CEO Purchase +665 $0.77 $509 102,568
2017-03-17 CAUWENBERGH GEERT President & CEO Purchase +15 $0.77 $11 102,583
2017-02-17 CAUWENBERGH GEERT President & CEO Purchase +200 $0.69 $138 82,783
2017-02-17 CAUWENBERGH GEERT President & CEO Purchase +6,883 $0.69 $5K 89,666
2017-02-17 CAUWENBERGH GEERT President & CEO Purchase +2,917 $0.70 $2K 92,583
2017-02-08 CAUWENBERGH GEERT President & CEO Purchase +10,000 $0.69 $7K 82,583
2017-02-01 Lockshin Curtis Director Grant or award · Stock option (right to buy) +2,000 2,000
2017-02-01 Dorman H. Paul Director Grant or award · Stock option (right to buy) +2,000 2,000
2017-02-01 Brownlie Keith L Director Grant or award · Stock option (right to buy) +2,000 2,000
2017-02-01 Bitterman Robert J Director Grant or award · Stock option (right to buy) +2,000 2,000
2017-02-01 Pavco Pamela Chief Development Officer Grant or award · Stock option (right to buy) +7,000 7,000
2017-02-01 Kontulis Caitlin Secretary & Dir. of Finance Grant or award · Stock option (right to buy) +2,500 2,500
2017-02-01 CAUWENBERGH GEERT President & CEO Grant or award · Stock option (right to buy) +13,000 13,000
2017-01-25 CAUWENBERGH GEERT President & CEO Purchase +300 $0.69 $207 62,883
2017-01-25 CAUWENBERGH GEERT President & CEO Purchase +9,700 $0.70 $7K 72,583
2017-01-19 CAUWENBERGH GEERT President & CEO Purchase +6,400 $0.70 $4K 58,983
2017-01-19 CAUWENBERGH GEERT President & CEO Purchase +3,000 $0.69 $2K 61,983
2017-01-19 CAUWENBERGH GEERT President & CEO Purchase +600 $0.69 $417 62,583

Page 9 of 13 · 258 trades